Yovis IBS is a probiotic food supplement containing Lacticaseibacillus paracasei DG® I1572 (DSM 34154), a strain of human origin characterized by its ability to survive throughout the gastrointestinal tract and adhere to the intestinal mucosa. Each capsule provides 24 billion live microorganisms, contributing to the rebalancing of the intestinal flora, which can be altered by various factors such as dietary changes or antibiotic use. Its formulation is distinguished by its natural protective exopolysaccharide capsule, produced by the bacterial strain itself, which helps protect the microorganisms against gastric acidity, digestive enzymes, and bile salts. This characteristic favors the arrival of probiotic bacteria in the intestine under viable conditions. It helps to rebalance the intestinal microbiota through a selected probiotic strain with high survival capacity and adhesion to the intestinal mucosa. The L. casei DG® strain also exhibits a high capacity for adhesion to intestinal mucosal cells and multiplication potential, characteristics that contribute to its persistence in the intestinal environment. Yovis IBS is free of lactose, milk proteins, and gluten, does not contain genetically modified organisms (GMOs), and is suitable for a vegan diet. It can be used by adults and children over 6 years of age, according to the manufacturer's recommendations. It is also suitable during pregnancy and breastfeeding.